INSIGHTS ON QUALITY ASSURANCE

• How To Overcome Common Single-Use Assembly Design Challenges

  Single-use systems offer major benefits in pharma manufacturing, but design complexity brings challenges. Learn how to overcome issues like scalability and quality assurance with integrated strategies.

• Smart Manufacturing: A Strategic Imperative For Pharma's Future

  Pharmaceutical manufacturing is evolving rapidly. Find out how digital technologies like AI, digital twins, and software-defined automation are driving smarter, more agile production.

• Pharmaceutical X-Ray Counts Capsules & Pills

  Learn how advanced X-ray inspection ensures exact pill counts in multi-supplement pouches, automatically identifying missing components and generating time-stamped visual data logs.

• Accelerating Method Development And Manufacturing Of GLP-1 Analogs

  Explore a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.

• Delving Into Gene Expression Data Analysis And Experimental Reproducibility

  3/5/2026

  Scientific reproducibility is essential for credible research. Learn to navigate standardized frameworks, refine normalization techniques, and ensure your data remains transparent and verifiable.

• Becton Dickinson: Enhancing Maintenance Compliance

  8/8/2025

  Learn how BD standardized calibration across 85 sites with a RAM to boost compliance, efficiency, and system integration for scalable, future-ready operations.

• Cambrex Scientist Spotlight: Ross McLellan

  1/29/2025

  Ross McLellan, Team Lead for Solid Form Screening in Edinburgh, UK, leads a team dedicated to complex solid form screening and materials characterization for Cambrex’s global client base.

• Pharma Continuous Manufacturing

  1/20/2026

  Transform your production with continuous manufacturing. Streamline processes, ensure consistent quality, and reduce costs by shifting from batch to agile operations that accelerate time-to-market.

• Risk Isn't Inevitable: How The Right CDMO Protects Your Programme

  4/13/2026

  Risk in outsourced drug development is often created, not inherent. Learn how CDMO structure, continuity, and communication directly affect programme risk, timelines, and outcomes.